MyFinsight
Home
Blog
About
Cash and cash
equivalents
$477,905K
(55.83%↑ Y/Y)
Short-term marketable debt
securities
$59,125K
(-50.06%↓ Y/Y)
Prepaid expenses
$26,447K
(-2.01%↓ Y/Y)
Other receivables
$6,561K
(92.46%↑ Y/Y)
Operating lease
right-of-use assets
$2,078K
(-7.69%↓ Y/Y)
Other non-current
assets
$1,344K
(-20.80%↓ Y/Y)
Property and equipment,
net
$487K
(-26.99%↓ Y/Y)
Total current assets
$570,038K
(25.15%↑ Y/Y)
Total non-current
assets
$3,909K
(-15.30%↓ Y/Y)
Total assets
$573,947K
(24.75%↑ Y/Y)
Total liabilities and
shareholders' equity
$573,947K
(24.75%↑ Y/Y)
Total shareholders
equity
$428,195K
(21.05%↑ Y/Y)
Total liabilities
$145,752K
(42.68%↑ Y/Y)
Accumulated deficit
-$594,423K
(-79.72%↓ Y/Y)
Additional paid-in capital
$1,021,980K
(49.42%↑ Y/Y)
Total non-current
liabilities
$100,360K
(34.19%↑ Y/Y)
Total current
liabilities
$45,392K
(65.90%↑ Y/Y)
Accumulated other
comprehensive income
$630K
(21.15%↑ Y/Y)
Common shares
$8K
(33.33%↑ Y/Y)
Long-term debt
$99,514K
(35.61%↑ Y/Y)
Long-term portion of
operating lease...
$772K
(-7.66%↓ Y/Y)
Pension liability
$74K
(-87.11%↓ Y/Y)
Accrued expenses and
other current...
$27,108K
(210.44%↑ Y/Y)
Trade and other
payables
$17,038K
(-0.24%↓ Y/Y)
Short-term portion of
operating lease...
$1,246K
(-19.61%↓ Y/Y)
Back
Back
Balance Sheet
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX)
source: myfinsight.com